Fingerprint
Dive into the research topics of 'Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically